 randomized clinical trial scatter photocoagulation proliferative sickle cell retinopathy randomized prospective clinical trial argon laser scatter photocoagulation therapy proliferative sickle cell retinopathy patients eyes Kingston Jamaica Ninety-nine eyes scatter photocoagulation eyes controls average length follow-up months control eyes months treated eyes Prolonged loss visual acuity treated eyes incidence vitreous hemorrhage treated eyes risk factors vitreous hemorrhage extent proliferative sickle cell retinopathy entry study complications argon laser scatter photocoagulation Scatter photocoagulation proliferative sickle cell retinopathy effective safe way patients sea fan neovascularization